Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: Role of Coenzyme Q10 in Chronic Kidney Disease [Phase 4]

View source ↗

Summary

This entry reports an ongoing Phase 4 clinical trial evaluating the role of Coenzyme Q10 in chronic kidney disease, currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Tanta University | Conditions: Chronic Kidney Diseases | Phase 4 | Status: RECRUITING